Resultados de Búsqueda

Compromiso por la calidad de las Sociedades Científicas en España

GuiaSalud

Repeating previously performed genetic tests—such as those for hereditary thrombophilia (R506Q, G20210A), type 1 hemochromatosis (C282Y, H63D), or DQ2/DQ8 haplotypes for celiac disease—offers no clinical benefit and represents an unnecessary expenditure of healthcare resources. Effective demand management in laboratory medicine should prevent redundant testing and promote rational use of diagnostics, especially in genetics, where results are stable over time. Automated systems that reject ...

Compromiso por la calidad de las Sociedades Científicas en España

GuiaSalud

In patients with prediabetes, HbA1c testing is not recommended at intervals shorter than 12 months unless specific clinical conditions apply. Evidence shows that progression to type 2 diabetes is gradual, and lifestyle interventions require time to be effective. More frequent screening does not improve outcomes, lacks cost-effectiveness, and may increase patient anxiety while overburdening healthcare systems. Monitoring should focus on supporting behavioral change, with more frequent testing ...

Compromiso por la calidad de las Sociedades Científicas en España

GuiaSalud

Umbilical cord clamping should not be performed before the first minute of life in clinically stable newborns. Optimal clamping, done when the cord is limp and pulseless, supports a physiological transition from placental to pulmonary circulation. It is associated with higher hemoglobin and iron stores and lowers the risk of infant anemia. Major international guidelines recommend delaying clamping for 1 to 3 minutes, even in preterm infants. Early clamping should only be considered when ...

Compromiso por la calidad de las Sociedades Científicas en España

GuiaSalud

In women with adequately progressing labor, vaginal examinations should not be performed more frequently than every 4 hours. This practice does not improve perinatal outcomes and increases the risk of maternal and neonatal infections, while also causing discomfort to the birthing person. Evidence indicates that the number of vaginal exams is a strong predictor of infection, particularly after premature rupture of membranes. Reducing exam frequency supports a respectful and safe childbirth care ...

Compromiso por la calidad de las Sociedades Científicas en España

GuiaSalud

The use of metoclopramide in children under 1 year and domperidone in those under 12 years is not recommended for treating nausea and vomiting due to limited efficacy and significant safety concerns. In pediatric patients aged 1 to 18, metoclopramide should only be considered as second-line therapy in chemotherapy or postoperative settings. These drugs carry substantial risks: metoclopramide is associated with extrapyramidal side effects, particularly in young children, and domperidone has been ...